News

MONTREAL, August 30, 2002 (LSN.ca) – The third-generation contraceptive pill, long promoted as a “safe” and even as a beneficial pregnancy-prevention method, has once again been declared “safe” in a new study—except for a “slightly increased risk of blood clots.”  The third generation, which includes the products Femodene, Femodette, Marvelon, Mercilon, Minulet, Triadene and Tri-Minulet currently on the market, has been found not to increase the risk of heart attacks in young women. However, the BBC reports, “there remains a slightly increased risk of blood clots with the newest pills.” Yet inexplicably, Britain’s High Court recently threw out a suit brought by 100 women who claimed that the third generation pill had caused blood clots.  The latest research, from McGill University and the University of Surrey in Guildford, England, was published in the journal Human Reproduction.  For the BBC News report see:  https://news.bbc.co.uk/2/hi/health/2223816.stm   To read the abstract from Human Reproduction see:  https://humrep.oupjournals.org/cgi/content/abstract/17/9/2307?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Spitzer%2C+W&searchid=1030717885539_840&stored_search=&FIRSTINDEX=0&fdate=1/1/2002&journalcode=humrep

Comments

Commenting Guidelines

LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.

LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.

Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).

LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.

Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.